- New drug to treat one of the deadliest cancers is 'the real deal,' oncologist says KSL.com
- Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer Nature
- Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib Medscape
- Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ Chicago Tribune
- 'Game changer' drug gives new hope in pancreatic cancer fight usatoday.com
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь